Medgold to Extend Convertible Debenture
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Vancouver, Canada, December 22, 2014, Medgold Resources Corp. (TSX-V: MED) (the “Company”) announces that its Board of Directors has determined that it is in the best interests of the Company to extend the expiry date of a debenture in the principal amount of $975,000 that was previously issued by the Company pursuant to a private placement. Accordingly, subject to TSX Venture Exchange acceptance, the expiry date of the debenture, which is convertible into 2,166,667 common[…]
Medgold Options Portugal Licences to Centerra Gold
Vancouver, Canada, December 9, 2014, Medgold Resources Corp. (TSX-V: MED), the European-focused gold exploration company, is pleased to announce that it has granted to Centerra Gold Inc. (TSX: CG) the option to acquire up to 70% of the Lagares, Balazar, Castelo de Paiva and Valongo licences in northern Portugal (collectively the “Valongo Belt Property”). Dan James, the President of Medgold, said, “The signing of the Option Agreement with Centerra is a significant milestone for the Company providing funding security for the project without immediate equity dilution and allowing us to plan[…]
Medgold Reports 69 m @ 4.15 g/t Au from Channel Sampling at the Lagares Gold Project, Portugal
Vancouver, Canada, 2nd December, 2014, Medgold Resources Corp. (TSX-V: MED), the European-focused gold exploration company, is pleased to announce high-grade gold results over broad contiguous intersections from a recent channel sampling program at the Lagares Gold Project in northern Portugal. Channel-Chip Sampling Highlights Management is extremely encouraged by the first round of channel sampling with 8 of 9 channels returning significant, broad widths of gold mineralization. Highlights of the results include: 69.00 m @ 4.15 g/t Au 40.70 m @ 5.73 g/t Au, including 5.20 m @ 15.50 g/t Au 15.50[…]
Medgold to Amend Warrants
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Vancouver, Canada, October 23, 2014, Medgold Resources Corp. (TSX-V: MED) (the “Company”) announces that its Board of Directors has determined that it is in the best interests of the Company to amend the exercise price of certain common share purchase warrants (the “Warrants”) issued in early 2014 pursuant to a private placement. In order to encourage exercise of the Warrants, the Warrant holders have been given the right, for a limited time, to elect to[…]
Medgold Identifies High-Grade Mineralization at the Ponte da Barca Gold Project, Portugal
Vancouver, Canada, September 24, 2014, Medgold Resources Corp. (TSX-V: MED), the European-focused gold exploration company, is pleased to announce new high-grade gold results for its Ponte da Barca gold project in northern Portugal. Recent work has identified a mineralized structure outcropping over a strike length of 400 m with rock-chip sample results ranging from trace up to 35.3g/t, 25.0g/t and 20.7 g/t Au. The high-grade results are from the main Coto de Cruz prospect, which is located in the east of the Ponte da Barca licence, and are from an[…]